Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
IUBMB Life|October 2, 2020
The immunomodulatory effects of mesenchymal stromal cell-based therapy in human and animal models of systemic lupus erythematosusFereshteh Radmanesh, Mahmoud Mahmoudi, Esmaeil Yazdanpanah, et al.
Heliyon|December 17, 2024
Distinct therapeutic effects of auraptene and umbelliprenin on TNF-α and IL-17 levels in a murine model of chronic inflammationSaeid Joveini, Fatemeh Yarmohammadi, Mehrdad Iranshahi, et al.
Science Signaling|August 5, 2025
Tumor-infiltrating nociceptor neurons promote immunosuppressionAnthony C Restaino, Maryam Ahmadi, Tuany Eichwald, et al.
Scientific Reports|April 10, 2023
Targeting the tumor microenvironment by liposomal Epacadostat in combination with liposomal gp100 vaccineSahar Tahaghoghi-Hajghorbani, Mona Yazdani, Amin Reza Nikpoor, et al.
International Journal of Nanomedicine|August 18, 2020
Encapsulated Checkpoint Blocker Before Chemotherapy: The Optimal Sequence of Anti-CTLA-4 and Doxil Combination TherapyReza Alimohammadi, Razieh Alibeigi, Amin Reza Nikpoor, et al.
Artificial Cells, Nanomedicine, and Biotechnology|January 30, 2019
Enhancement of the effect of BCG vaccine against tuberculosis using DDA/TDB liposomes containing a fusion protein of HspX, PPE44, and EsxVDavood Mansury, Kiarash Ghazvini, Saeid Amel Jamehdar, et al.
Scientific Reports|June 21, 2022
CD73 downregulation by EGFR-targeted liposomal CD73 siRNA potentiates antitumor effect of liposomal doxorubicin in 4T1 tumor-bearing miceAnvar Soleimani, Farshad Mirzavi, Sara Nikoofal-Sahlabadi, et al.
Reports of Biochemistry & Molecular Biology|February 27, 2019
Increasing Cellular Immune Response in Liposomal Formulations of DOTAP Encapsulated by Fusion Protein Hspx, PPE44, And Esxv, as a Potential Tuberculosis Vaccine CandidateDavood Mansury, Kiarash Ghazvini, Saeid Amel Jamehdar, et al.
Pageof 10